BCK Capital Management’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-13,926
Closed -$185 106
2023
Q2
$185 Hold
13,926
﹤0.01% 65
2023
Q1
$712 Buy
+13,926
New +$1.24K ﹤0.01% 70

BCK Capital Management's GRNAW Position: Q3 2023 in Review

BCK Capital Management sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q3 2023, closing a stake of 13,926 shares — an estimated $185 sold.

BCK Capital Management first reported a position in GRNAW in Q1 2023 and held it in 2 quarters. The position peaked at $712 in Q1 2023. 1 fund tracked by Wall St. Rank holds GRNAW as of Q3 2023.

  • BCK Capital Management reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q3 2023 after selling out during the quarter.
  • BCK Capital Management sold 13,926 GreenLight Biosciences Holdings, PBC Warrant shares in Q3 2023, an estimated $185.
  • BCK Capital Management first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q1 2023 and held it in 2 quarters.
  • BCK Capital Management's GreenLight Biosciences Holdings, PBC Warrant position peaked at $712 in Q1 2023.
  • 1 fund tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q3 2023.

Based on BCK Capital Management's 13F filing for Q3 2023, filed 8 Nov 2023.